NASDAQ:NTRB

Nutriband Stock Insider Trading

Healthcare > Biotechnology

Buy NTRB

*Your capital is at risk

$3.51

-0.0400 (-1.13%)

At Close: Jun 03, 2026

Nutriband Stock Insider Power

Based on the 72 latest insides trades, we have calculated the insider power to be positive at 99.02. In total, the insiders bought 1.49M and sold 3.05M NTRB shares in the last 72 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 72 transactions)	99.02
● Buy	1.49M shares
● Sell	3.05M shares
82% Buy Activity Negligible or No Correlation
Buy Signal Medium Confidence Jun 01, 2026 Analysis Breakdown: Strongly supported by a very high Insider Power Score of 99.02. Signal is based on a moderate data reliability score of 60. Supported by overwhelming buy-side pressure (82% buys).

Historical Insider Trades

Date	Type	Person	Role	Amount
Jan 31, 2025 Buy	Common Stock	Sheridan Gareth Chief Executive Officer	CEO / President	0 Value: $0
Jan 29, 2025 Buy	Stock Option A-Award	Sheridan Gareth Chief Executive Officer	CEO / President	29 333 Value: $236.7K
Jan 23, 2025 Buy	Stock Option A-Award	Goodman Gerald Chief Financial Officer	C-Suite Officer	17 667 Value: $129.7K
Jun 06, 2024 Buy	Stock Warrant M-Exempt	Goodman Gerald Chief Financial Officer	C-Suite Officer	87 500 Value: $168.9K
Jun 06, 2024 Buy	Stock Warrant M-Exempt	Goodman Gerald Chief Financial Officer	C-Suite Officer	87 500 Value: $168.9K
Jun 05, 2024 Sell	Warrant X-InTheMoney	Goodman Gerald Chief Financial Officer	C-Suite Officer	60 085 Value: $116.0K
Mar 20, 2024 Buy	Stock Option A-Award	Sheridan Gareth Chief Executive Officer	CEO / President	97 500 Value: $254.5K
Mar 20, 2024 Buy	Stock Option A-Award	Goodman Gerald Chief Financial Officer	C-Suite Officer	75 000 Value: $177.8K
Mar 20, 2024 Buy	Stock Option A-Award	Goodman Gerald Chief Financial Officer	C-Suite Officer	75 000 Value: $177.8K
Mar 20, 2024 Buy	Options to Purchase Common Stock A-Award	Sheridan Gareth CEO	CEO / President	75 000 Value: $177.8K
Mar 20, 2024 Buy	Options to Purchase Common Stock A-Award	Melnik Serguei President And Secretary	CEO / President	97 500 Value: $254.5K
Mar 20, 2024 Buy	Options to Purchase Common Stock A-Award	Sheridan Gareth CEO	CEO / President	75 000 Value: $177.8K
Mar 20, 2024 Buy	Options to Purchase Common Stock A-Award	Melnik Serguei President And Secretary	CEO / President	97 500 Value: $254.5K
Mar 19, 2024 Buy	Stock Option A-Award	Goodman Gerald Chief Financial Officer	C-Suite Officer	75 000 Value: $144.8K
Oct 27, 2023 Buy	Stock Option A-Award	Goodman Gerald Chief Financial Officer	C-Suite Officer	49 500 Value: $95.5K
Oct 27, 2023 Buy	Stock Option A-Award	Goodman Gerald Chief Financial Officer	C-Suite Officer	49 500 Value: $95.5K
Mar 06, 2023 Sell	Common Stock, par value $0.001 per share G-Gift	Melnik Serguei Chairman And President	CEO / President	5 000 Value: $0
Mar 06, 2023 Sell	Common Stock, par value $0.001 per share G-Gift	Melnik Serguei Chairman And President	CEO / President	5 000 Value: $0
Dec 09, 2022 Buy	Stock Option A-Award	Goodman Gerald Chief Financial Officer	C-Suite Officer	20 000 Value: $70.6K
Dec 09, 2022 Buy	Stock Option A-Award	Goodman Gerald Chief Financial Officer	C-Suite Officer	20 000 Value: $70.6K
Aug 16, 2022 Buy	Stock Option A-Award	Goodman Gerald Chief Financial Officer	C-Suite Officer	23 333 Value: $95.4K
Aug 16, 2022 Buy	Stock Option A-Award	Goodman Gerald Chief Financial Officer	C-Suite Officer	23 333 Value: $95.4K
May 10, 2022 Sell	Common Stock G-Gift	Sheridan Gareth CEO	CEO / President	10 000 Value: $0
May 10, 2022 Buy	Common Stock A-Award	Sheridan Gareth CEO	CEO / President	10 000 Value: $38.0K
May 10, 2022 Buy	Common Stock A-Award	Sheridan Gareth CEO	CEO / President	10 000 Value: $38.0K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT NUTRIBAND INC.

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. It also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; e...

Read Full Profile Here